Technavio has been monitoring the global active pharmaceutical ingredients market since 2015 and the market is poised to grow by USD 60.56 billion during 2020-2024, progressing at a CAGR of more than 6% during the forecast period. Request a free sample report
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200106005072/en/
Technavio has announced its latest market research report titled global active pharmaceutical ingredients market 2020-2024. (Graphic: Business Wire)
Read the 156-page report with TOC on "Active Pharmaceutical Ingredients Market Analysis Report by Geography (Asia, Europe, North America, and ROW), Manufacturing type (Captive API and Contract API), and the Segment Forecasts, 2020-2024."
The market is driven by the increasing number of type II drug master files (DMFs). In addition, a paradigm shift in API manufacturing is anticipated to boost the growth of the active pharmaceutical ingredients market.
The market has witnessed a steady rise in the number of DMF filings over the past two decades. This is due to the increasing investments to enhance manufacturing facilities by Asian companies to meet international quality standards. In addition, market players in India are increasingly focusing on achieving compliance with standards laid by various regulatory agencies such as the US FDA, TGA, MHRA, Brazilian Health Regulatory Agency, and SAHPRA. The increasing DMF approvals by regulatory agencies are providing significant growth opportunities for API manufacturers. These factors are fueling the growth of the global active pharmaceutical ingredients market.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Major Five Active Pharmaceutical Ingredients Market Companies:
Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc. operates the business across segments such as Generics and Specialty. The company performs captive manufacturing of APIs for its own finished pharmaceutical products.
Cadila Healthcare Ltd.
Cadila Healthcare Ltd. operates the business in the Pharmaceuticals segment. The company offers 38 APIs and intermediates across various therapeutic categories.
Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals Plc operates its business through the Unified business segment. The company offers a wide range of APIs used for the manufacture of various finished pharmaceutical products.
Lupin Ltd. operates the business through the Pharmaceuticals segment. The segment focuses on the discovery, development, manufacture, and commercialization of finished pharmaceutical products and APIs. The company offers a wide range of APIs used for the manufacture of various finished pharmaceutical products.
Mylan NV operates the business across segments such as Gx, Rx/Bx, and OTC. The company offers a wide range of APIs used for the manufacture of various finished pharmaceutical products across various therapeutic areas, such as HIV/AIDS, antibacterials, central nervous system agents, antihistamines/anti-asthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitors.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio has segmented the active pharmaceutical ingredients market based on the manufacturing type and region.
Active Pharmaceutical Ingredients Manufacturing Type Outlook (Revenue, USD Billion, 2020 - 2024)
- Captive API
- Contract API
Active Pharmaceutical Ingredients Regional Outlook (Revenue, USD Billion, 2020 - 2024)
- North America
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report.
Related Reports on Healthcare include:
Global Pruritus Drugs Market – Global pruritis drugs market by application (hematologic pruritus, oncological pruritus, renal pruritus, endocrine pruritus, and cholestatic pruritus), RoA (topical, oral, and parenteral) and geography (Asia, Europe, North America, and ROW).
Global Uveitis Drugs Market – Global uveitis drugs market by product (small molecules and biologics) and geography (Asia, Europe, North America, and ROW).
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at firstname.lastname@example.org
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Follow Us: LinkedIn | Twitter